Federal Register Notice: FDA is establishing the Risk Communication Advisory Committee, which will provide advice to the commissioner or designee on strategies and programs designed to communicate with the public about both the risks and benefits of FDA-regulated products so as to facilitate optimal use of these products. The committee also reviews and evaluates research relevant to such communication to the public by both FDA and other entities and facilitates interactively sharing risk and benefit information with the public to enable people to make informed independent judgments about use of FDA-regulated products. To view this notice, click here.